Tetranitromethane reacts with essentially all 21 tyrosine residues of iron-free ovotransferrin. In iron-ovotransferrin, 7 mol of tyrosine/mol of protein are unreactive.
atoms is discussed.
The involvement of tyrosine residues in iron binding by transferrin was first indicated by the observation that six protons are released from side groups with PKa values greater than 10.0 when two atoms of iron are bound (Warner & Weber, 1953) . Later it was found that six fewer tyrosine residues can be titrated in iron-ovotransferrin than in the iron-free protein (Wishnia et al., 1961) . Supporting evidence for the role of tyrosine was provided by resonance Raman spectroscopy (Tomimatsu et al., 1976; Carey & Young, 1974) , proton magnetic resonance (p.m.r.) (Woodworth et al., 1970), u.v. difference spectroscopy (Tan & Woodworth, 1969) , circular dichroism (c.d.) (Mazurier et al., 1976 ) and electron-paramagnetic-resonance (e.p.r.) spectroscopy (Aasa et al., 1963; Windle et al., 1963) . Most of these studies show that three tyrosine residues are involved in the binding of each ferric ion, although Tan & Woodworth (1969) obtained a value of two. Chemical modification of tyrosine by nitration with tetranitromethane (Bezkorovainy & Grohlich, 1972; Line et al., 1967; Teuwissen et al., 1973; Tsao et al., 1974) , iodination (Phillips & Azari, 1972) or acetylation (Komatsu & Feeney, 1967) destroys the iron-binding ability of iron-free transferrin. In the iron-saturated protein, 2-3 mol of tyrosine/metal atom bound remain unmodified and the modification of the other tyrosine residues does not lead to loss of the bound iron. These reagents do not distinguish between tyrosine residues in the ironbinding sites of iron-free transferrin and those elsewhere in the molecule. With periodate, however, Azari & Phillips (1970) found that three to five tyrosine residues out of the total number of 21 in iron-free ovotransferrin underwent rapid oxidation with loss of the iron-binding ability. No destruction Vol. 201 of tyrosine occurred on periodate treatment of the iron-protein. Geoghegan et al. (1980) confirmed this observation and proposed that the oxidizable tyrosine residues are those that function as ligands to the metal atoms. They also found that urea denaturation largely protects the binding-site tyrosine residues against oxidation, which suggests that their special reactivity may depend on the integrity of the native structure of the protein.
An essential step in elucidating the structure of the iron-binding sites is the location of the tyrosine ligands in the primary structure of the protein. The only study in which this has been attempted appears to be that by Tsao et al. (1974) , in which peptides containing unmodified tyrosine were detected in trypsin digests of nitrated iron-ovotransferrin. Attempts to purify these peptides were not successful and the work was greatly hampered by the fact that the amino acid sequence of ovotransferrin was not known at that time. Jeltsch & Chambon (1981) have recently deduced the amino acid sequence of ovotransferrin from the nucleotide sequence of the corresponding mRNA. This sequence contains 21 tyrosine residues and when the N-terminal and C-terminal halves of the sequence are aligned so as to give the greatest number of identical matching residues, it is seen that there are six pairs of matching tyrosine residues (Williams et al., 1981) . These 'conserved' pairs of tyrosine residues are at positions 82 and 415, 92 and 431, 188 and 521, 191 and 524, 239 and 581 and at The experiments described in the present paper, which were carried out in 1968, attempt to identify those tyrosine residues in the iron-ovotransferrin complex that are unreactive towards tetranitromethane. Ten such residues are identified and some of them form conserved pairs. No straightforward identification of the iron ligands can be made from these results.
Materials and methods
Hen ovotransferrin was prepared as described by Williams (1968) . Iron was removed by the method of Warner & Weber (1951) (1963) and digested with trypsin (Worthington), by using an enzyme-to-substrate ratio of 1:50 (w/w). The buffer was 1% (NH4)2CO3 and digestion was continued for 1 2h at 37°C.
Fractionation ofpeptides Preliminary fractionation of peptides was carried out by ion-exchange chromatography on a column (150cm x 2cm) of Dowex 50 X2 resin (Bio-Rad AG, 50W, X2, 200-400 mesh) with volatile pyridine/ acetic acid buffers (Schroeder, 1967) . The column was loaded with 2g of protein digest in 20ml of pyridine/acetic acid buffer (pH 2.7, pyridine concentration 0.2M). Peptides were eluted with a linear gradient from pH 3.1 (pyridine concn. 0.2 M) to pH 5.0 (pyridine concn. 2.0M). A 2-litre portion of each buffer was used in forming the gradient. The column was surrounded by a water jacket at 37°C.
A flow rate of 45 ml/h was used and 9 ml fractions were collected.
Fractions containing tyrosyl or tryptophyl peptides were detected with the Folin reagent (Lowry et al., 1951) . A sample (0.5 ml) of each fraction was mixed with 3.5 ml of 2% (w/v) Na2CO3 in 0.5 MNaOH and 0.2 ml of Folin-Ciocalteu reagent (diluted 1:1 with water). The A500 was measured after 30min. Peptide-containing fractions were pooled and rotary-evaporated. The selectivity of this reagent for tyrosyl and tryptophyl peptides was achieved by the omission of the copper reagent.
Further purification of peptides was carried out by high-voltage paper electrophoresis at pH 6.5, 3.5 and 2.1 (Ambler, 1963) . Papers were stained with a cadmium acetate/ninhydrin reagent (Heilmann et al., 1957) and with 1-nitroso-2-naphthol (Jepson & Smith, 1953) , which gives a red colour with tyrosine-containing peptides but which does not react with 3-nitrotyrosine. Electrophoretic mobilities of peptides at pH 6.5 relative to that of aspartic acid were measured (Offord, 1966) .
The amino acid compositions of peptides were determined with a Technicon TSM-1 analyser after hydrolysis with 5.7M-HCI at 105°C for 24h. Sequences were determined by the dansyl-Edman method (Gray & Hartley, 1963; Gray, 1967) .
Results

Tvrosine determinations
The nitrotyrosine content of tetranitromethanetreated iron-free ovotransferrin, as estimated from Lysl0. The amino acid sequence was Ala-Thr-TyrLeu-Asp-CMCys-Ile-Lys.
Discussion
Ovotransferrin contains 21 tyrosine residues (Jeltsch & Chambon, 1981) . Tetranitromethane treatment of iron-free ovotransferrin gives essentially complete nitration of tyrosine, and the small amount of remaining tyrosine has not been studied further in these experiments. The amount of unreactive tyrosine in iron-ovotransferrin is about 7mol/mol of protein (7.6 by the A430 and 7.1 by amino acid analysis). These results are in complete agreement with those of Tsao et al. (1974) . Fig. 1 shows the amino acid sequence of hen ovotransferrin as deduced from the mRNA sequence (Jeltsch & Chambon, 1981) . Of the 17 peptides containing unmodified tyrosine residues, 15 can readily be located in this sequence. In the case of peptide P7, the structure differs from that deduced from the mRNA in that glutamine replaces the glutamic acid at position 519. At present, nine sites in ovotransferrin appear to show polymorphism (Williams et al., 1981) . Peptide P9 (Val-Tyr-Glu) cannot be definitely identified in the sequence, but it may be tentatively suggested that it corresponds to Ile-Tyr-Glu at positions 81-83. Peptide T2 cannot be fitted to the sequence and is presumably a contaminant. From these data (Fig. 1 ) the tyrosine residues that are protected from reaction with Fig. 1 . Amino acid sequence ofhen ovotransferrin as deducedfrom the mRNA sequence (Jeltsch & Chambon, 1981) The N-terminal sequence from residue -19 to residue -1 forms the pre-sequence which is absent from the secreted protein. Lines below the sequence show the probable locations of the peptides which contain protected tyrosine residues. These residues are numbered. The one-letter code for the amino acids is as follows: A, alanine; C, cysteine; In addition to the protection of tyrosine residues that are directly bound to the metal atoms, other tyrosine residues could be made unavailable to the reagent by the conformational changes that accompany iron binding. From the present results no distinction between the two types of protected tyrosine residues can be made. However, some attempt at distinguishing the two types can be made on the assumption that the iron ligands in the N-terminal and C-terminal domains of transferrin are homologous. Thus eight of the protected tyrosine residues occur as 'conserved' pairs at positions 82, 92, 188 and 191 in the N-terminal domain and at positions 415, 431, 521 and 524 in the C-terminal domain. There was no evidence of protection of the other two pairs of 'conserved' tyrosine residues (at positions 239, 325, 581 and 662). The protected tyrosine residues at positions 42 and 319 in the N-terminal domain have no matching tyrosine partners in the C-terminal domain and it is therefore unlikely that they are iron ligands. Thus it is now possible to restrict the choice of the six iron-binding tyrosine residues to eight out of the total number of 21. Clearly, it would be of great interest to know the identities of the four tyrosine residues that undergo selective oxidation by periodate (Geoghegan et al., 1980 
